SCHEMBL16236529

SCHEMBL16236529

Cc1[nH]c(C(=O)Nc2ccc(F)c(OC(F)(F)F)c2)cc1S(=O)(=O)Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.43
▸ TDO2 P48775 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ EPHX2 P34913 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GSTO1 P78417 1/20 0.40
▸ RORC P51449 2/20 0.40
▸ BRAF P15056 1/20 0.40
▸ IDH1 O75874 3/20 0.39
▸ GRM4 Q14833 2/20 0.39
▸ AKT1 P31749 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PRNP P04156 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16237501 0.84 RAB9A (0.48) KDM4EMEN1LMNAMAPK1KMT2A
SCHEMBL16237067 0.84 GRM4 (0.41) KDM4EMEN1MAPK1KMT2ASMN1; SMN2
SCHEMBL16236610 0.83 NPC1 (0.49) IDO1TDO2KDM4EMEN1MAPK1
SCHEMBL16237029 0.81 CYP1A2 (0.41) KDM4EMEN1LMNAMAPK1KMT2A
SCHEMBL16237208 0.79 GRM4 (0.50) KDM4EMEN1MAPK1KMT2AGRM4
SCHEMBL16237215 0.77 CYP1A2 (0.45) KDM4ENPC1ALDH1A1PRNPGAA
SCHEMBL16236925 0.74 CYP1A2 (0.36) KDM4EMEN1KMT2ANPC1ALDH1A1
SCHEMBL10116449 0.74 LMNA (0.48) EPHX2MEN1LMNAMAPK1KMT2A
SCHEMBL16236340 0.74 ENPP2 (0.43) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL16236530 0.74 TP53 (0.48) EPHX2MEN1LMNAKMT2ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997011-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Janssen Sciences Ireland UC (IE) 2016-03-23 — — EP disclosed
WO-2014184350-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN R&D IRELAND (IE) 2014-11-20 — — WO disclosed
Send feedback